Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.41−0.29 (-3.77%)
Close on Nov 17, 2026Market cap $671.08MP/E –Yield –
Verastem total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Verastem's total debt was $25.06M at Sep 30, 2018. For fiscal 2017 it was $14.83M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $14.83M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | $25.06M | +973.4% |
| Q2 FY2018 | Jun 30, 2018 | $24.90M | +986.1% |
| Q1 FY2018 | Mar 31, 2018 | $14.91M | +563.1% |
| Q4 FY2017 | Dec 31, 2017 | $14.83M | – |
| Q3 FY2017 | Sep 30, 2017 | $2.34M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.29M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.25M | – |
See a number that looks wrong?